Increasing Demand For Personalized Medicine Driving Growth Of The Market Due To Advances In Genomics And Targeted Therapies: A Key Catalyst Accelerating Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for artificial intelligence (AI) in in vitro diagnostics (IVD) has seen rapid expansion in the past few years. The market is predicted to increase from $2.57 billion in 2024 to $3.04 billion in 2025, at a compound annual growth rate (CAGR) of 18.5%. The historical growth can be accredited to factors such as the increasing deficit of proficient healthcare providers and radiologists, growing governmental and regulatory backing for AI-based diagnostics, the rising use of AI in genomic and molecular diagnostics, an increased awareness among clinicians about the precision offered by AI-enabled diagnostics, and an increase in the availability of cloud-based AI diagnostic solutions.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Size Forecast: What's the Projected Valuation by 2029?
The market size of artificial intelligence (AI) in in vitro diagnostics (IVD) is predicted to experience a substantial expansion in the upcoming years, increasing to $5.94 billion by 2029 with a compound annual growth rate (CAGR) of 18.2%. Drivers of growth during the forecast period include the escalating demand for swift and precise diagnostic outcomes, the increasing occurrences of chronic and infectious diseases, a greater emphasis on personalized and precision medical remedies, a heightened focus on the early identification and prevention of diseases, and the augmentation of healthcare digitalization and the uptake of electronic health records (EHR). Dominant trends anticipated during the forecast period are progress in deep learning for pathology and imaging, innovation in fully automated high-capacity analyzers, the application of natural language processing in diagnostic reporting, advances in AI-powered remote diagnostic platforms, and the assimilation of AI with wearable and point-of-care devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

What Are the Drivers Transforming the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
As personalized medicine gains traction, it is predicted to drive the expansion of the artificial intelligence (AI) in the in vitro diagnostics (IVD) sector. Personalized medicine takes a tailored approach to prevention, diagnosis, and treatment, factoring in elements such as an individual's genetic makeup, lifestyle, and environment. Improved genomic data and sequencing technologies are leading to an increase in personalized medicine, bolstering more precise and effective treatments for each patient. AI in IVD supports personalized medicine by analyzing intricate diagnostic data to pinpoint patterns specific to a patient's disease, which assists in making more exact, timely, and individualized treatment choices. For example, the Personalized Medicine Coalition, an American non-profit organization, reported in February 2024 that the FDA had approved 16 new personalized treatments designed specifically for patients with rare diseases in 2023. This was a significant increase from the six treatments approved in 2022. Seven cancer drugs and three medications for other diseases and conditions were included in the personalized treatments approved for 2023. Therefore, the rise in demand for personalized medicine is fuelling the growth of the AI in IVD market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Long-Term Trends Will Define the Future of the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major businesses in the artificial intelligence (AI) in in vitro diagnostics (IVD) sector are concentrating on innovating advanced solutions like CE-IVDR-certified transparent AI platforms, aiming to improve diagnostic precision, simplify workflows, and cater to personalized patient care. Such a platform equips an AI system for in vitro diagnostics to comply with EU regulation standards, promoting clear, auditable, and comprehensible decision-making. For example, Diagnostics.ai, a UK- based diagnostic testing firm, introduced PCR.AI, an intelligent solution to expedite and augment PCR diagnostics, in May 2025. Achieving over 99.9% accuracy, it automates and speeds up the interpretation of real-time PCR diagnostics. It also assures regulatory adherence and boosts clinical confidence by transparently demonstrating how each outcome is calculated. This greatly improves laboratory productivity, minimizes mistakes, and enables smooth regulatory compliance for molecular diagnostics.

Which Segments in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Offer the Most Profit Potential?
The artificial intelligence (AI) in in vitro diagnostics (IVD) market covered in this report is segmented as

1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Which Firms Dominate the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market by Market Share and Revenue in 2025?
Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

Which Regions Offer the Highest Growth Potential in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28120

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.